Drug Profile


Alternative Names: AL 03432A; CGP 42125; Daren; Emadine; Eurodastin; KB 2413; KG 2413; LY 188695; Remicut

Latest Information Update: 27 Aug 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nippon Organon
  • Developer Alcon; Kolon Pharmaceuticals; Kowa; MSD KK; Saluc Pharma
  • Class Antiallergics; Antihistamines; Benzimidazoles; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Allergic conjunctivitis; Allergic rhinitis; Atopic dermatitis; Dermatitis; Urticaria
  • Discontinued Allergic asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis

Most Recent Events

  • 26 Aug 2010 Alcon has been acquired by Novartis
  • 16 Oct 2006 Discontinued - Clinical-Phase-Unknown for Allergic asthma in Japan (PO)
  • 16 Oct 2006 No development reported - Preregistration for Perennial allergic rhinitis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top